title: From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
authors.affiliation: Orthopaedic Surgery Service, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, MD, USA. Benjamin.k.potter.mil@mail.mil.|Walter Reed National Military Medical Center, 8901 Wisconsin Ave., America Building (19), 2nd Floor - Ortho, Bethesda, MD, 20889, USA. Benjamin.k.potter.mil@mail.mil.
authors.forename: Benjamin K
authors.initials: BK
authors.lastname: Potter
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D000069448:Denosumab / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004059:Diffusion of Innovation; D016527:Drug Costs; D055808:Drug Discovery / Q000191:economics / Q000639:trends; D006801:Humans; D058990:Molecular Targeted Therapy / Q000191:economics / Q000639:trends; D012109:Research Support as Topic; D057170:Translational Research, Biomedical / Q000191:economics / Q000639:trends
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D000069448:Denosumab